Pelvic floor dysfunction Musculoskeletal Diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Women self-reported symptoms of pelvic floor dysfunction, which could include urinary incontinence, pelvic organ prolapse, or sexual dysfunction. 2. They perceived vaginal laxity, defined as a score of 4 or higher on the Vaginal Laxity Questionnaire (VLQ). 3. They were able to complete validated questionnaires used in the study. 4. They provided written informed consent to participate. 5. They authorized the use of their anonymized clinical data for research purposes.
Exclusion criteria
Exclusion criteria: 1. Previous vaginal laser therapy 2. Contraindications to non-ablative vaginal laser 3. Concomitant interventions expected to confound outcomes during the evaluation period, such as pelvic floor physiotherapy, vaginal radiofrequency, or other concurrent treatments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At baseline (prior to the first laser session), follow-up 1 (6–8 weeks after the first session), follow-up 2 (6–8 weeks after the second session): 1. The vaginal hiatus was assessed following the criteria set forth by the joint report of the International Continence Society and the International Urogynecological Association (ICS/IUGA) on terminology for female pelvic floor dysfunction 2. Total vaginal length was defined as the distance in centimeters from the posterior fornix to the hymen, with point C or D reduced to its normal position. | — |
Secondary
| Measure | Time frame |
|---|---|
| At baseline (prior to the first laser session), follow-up 1 (6–8 weeks after the first session), follow-up 2 (6–8 weeks after the second session): 1. Pelvic floor muscle strength was assessed by vaginal palpation using the Oxford scale 2. Sexual function was evaluated with the self-administered Female Sexual Function Index (FSFI), which assesses six domains (desire, arousal, lubrication, orgasm, satisfaction, pain) | — |
Countries
Spain